+91 8766 590 1366 sales@chemreports.com

Your Order

Home Reports

Bortezomib API Global Market

Bortezomib API Global Market

Global Bortezomib API Market Industry Research Report 2026

Explore detailed insights, trends, growth drivers, key players, and forecasts for the Global Bortezomib API Market Industry Research Report 2026 market worldwide.

Pages: 190

Format: PDF

Date: 01-2026

Select Licence

Description Table of Content Key Players & Segment Request for Free Sample

Global Bortezomib API Market Report (2026–2036)

Market Overview

Chem Reports projects that the Bortezomib API Market, valued at USD xxxx units in 2025, is expected to reach USD xxxx units by 2036, growing at a CAGR of xx% globally.

The Global Bortezomib API Market Report 2025 provides an extensive industry analysis of development drivers, market patterns, flows, and sizes. It calculates present and historical market values to forecast potential market performance during 2026–2036. This research integrates both primary and secondary data sources, examining government policies, market environment, competitive landscape, historical data, current trends, technological innovation, upcoming technologies, and technical progress in related industries.

Impact of COVID-19

Since the outbreak of COVID-19 in December 2019, the pandemic has spread worldwide, with the World Health Organization declaring it a public health emergency. The global impacts of COVID-19 significantly affected the Bortezomib API market in 2020, disrupting supply chains, altering demand patterns, and reshaping investment priorities across pharmaceutical manufacturing and oncology drug supply chains.

Market Segmentation

By Type

  • Purity ≥ 98%
  • Purity ≥ 99%

By Application

  • Injection
  • Others

Regional Analysis

  • North America: U.S., Canada, Mexico
  • Europe: Germany, U.K., France, Italy, Russia, Spain, others
  • Asia-Pacific: China, India, Japan, Southeast Asia, others
  • South America: Brazil, Argentina, others
  • Middle East & Africa: Saudi Arabia, South Africa, others

Competitive Landscape

Top key players covered in the Bortezomib API market include:

  • Scion Pharm Taiwan
  • Vinkem Labs
  • Shilpa Medicare Limited
  • Farmhispania Group
  • Icrom
  • Tapi Teva
  • Chem-Stone (Guangzhou)
  • Gland Chemicals
  • Dr. Reddy's Laboratories
  • Qilu Pharmaceutical
  • Chengdu Aslee Biopharmaceuticals
  • Coresyn
  • Hubei Honch Pharmaceutical

Global Bortezomib API Market Intelligence Brief (2026–2036)

Short Description / Definition

Bortezomib is a proteasome inhibitor API, primarily used in injectable formulations for the treatment of multiple myeloma and mantle cell lymphoma. It works by disrupting proteasome-mediated protein degradation, leading to cancer cell apoptosis. The market is shaped by oncology demand, regulatory compliance, and pharmaceutical innovation, particularly in generics and hospital-based treatments.

Regional Analysis

  • North America: Strong demand in oncology APIs, with the U.S. leading due to FDA oversight, advanced healthcare infrastructure, and high cancer prevalence.
  • Europe: Growth driven by generics and strict EMA regulations. Germany, France, and Italy are key hubs for oncology drug manufacturing.
  • Asia-Pacific: Fastest-growing region, led by China and India, supported by large-scale generic production and government healthcare initiatives.
  • South America: Moderate growth, with Brazil showing demand in oncology treatments.
  • Middle East & Africa: Emerging adoption in oncology care, though market penetration remains limited compared to other regions.

Porter’s Five Forces

  1. Competitive Rivalry: High; global players (Scion Pharm Taiwan, Shilpa Medicare, Dr. Reddy’s, Qilu Pharmaceutical, Teva, Farmhispania) compete with regional manufacturers.
  2. Threat of New Entrants: Moderate; entry barriers include GMP compliance, regulatory approvals, and capital-intensive production.
  3. Bargaining Power of Suppliers: Moderate; raw material suppliers hold leverage due to limited sources of intermediates.
  4. Bargaining Power of Buyers: High; hospitals and oncology centers demand cost-effective, compliant APIs.
  5. Threat of Substitutes: Moderate; alternative proteasome inhibitors (e.g., Carfilzomib, Ixazomib) exist but Bortezomib remains relevant due to established efficacy.

SWOT Analysis

Strengths

  • Established use in multiple myeloma and mantle cell lymphoma.
  • Strong demand in hospital oncology care.
  • Proven efficacy as a first-in-class proteasome inhibitor.

Weaknesses

  • High production and compliance costs.
  • Dependence on complex synthesis pathways.

Opportunities

  • Rising global cancer prevalence.
  • Growth in Asia-Pacific generic manufacturing.
  • Development of combination therapies with Bortezomib (e.g., with lenalidomide or dexamethasone).

Threats

  • Raw material price volatility.
  • Stringent regulatory hurdles.
  • Competition from newer proteasome inhibitors.

Trend Analysis

  • Increasing use in oncology APIs for hematological cancers.
  • Rising demand in generic formulations across Asia-Pacific.
  • Growth in injectable formulations for hospital-based treatments.
  • Expansion of pharmaceutical R&D in combination therapies and resistance management.

Drivers & Challenges

Drivers

  • Expanding global oncology drug market.
  • Rising prevalence of hematological cancers worldwide.
  • Technological advancements in API manufacturing.

Challenges

  • High R&D and compliance costs.
  • Regulatory restrictions on oncology APIs.
  • Supply chain disruptions for raw materials.

Value Chain Analysis

  • Raw Materials: Specialized intermediates, solvents.
  • Manufacturing: API synthesis, purification, GMP compliance.
  • Distribution: Global distributors, pharmaceutical partnerships.
  • End-Use Industries: Pharmaceuticals, hospitals, oncology centers.
  • Regulatory Bodies: FDA, EMA, WHO shaping compliance requirements.

Quick Recommendations for Stakeholders

  • Manufacturers: Invest in R&D for cost-efficient production and combination therapies.
  • Investors: Focus on Asia-Pacific oncology markets where growth potential is strongest.
  • Regulators: Support harmonized global standards for oncology APIs.
  • Pharma Companies: Collaborate with API suppliers to ensure compliance and cost efficiency.
  • Distributors: Expand presence in emerging markets with campaigns highlighting therapeutic relevance.

Explore more reports here-

https://chemreports.com/reports

 

 

1. Market Overview of Bortezomib API
    1.1 Bortezomib API Market Overview
        1.1.1 Bortezomib API Product Scope
        1.1.2 Market Status and Outlook
    1.2 Bortezomib API Market Size by Regions:
    1.3 Bortezomib API Historic Market Size by Regions
    1.4 Bortezomib API Forecasted Market Size by Regions
    1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
        1.5.1 North America
        1.5.2 East Asia
        1.5.3 Europe
        1.5.4 South Asia
        1.5.5 Southeast Asia
        1.5.6 Middle East
        1.5.7 Africa
        1.5.8 Oceania
        1.5.9 South America
        1.5.10 Rest of the World
    1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
        1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2025 Projections
        1.6.2 Covid-19 Impact: Commodity Prices Indices
        1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Bortezomib API Sales Market by Type
    2.1 Global Bortezomib API Historic Market Size by Type
    2.2 Global Bortezomib API Forecasted Market Size by Type
    2.3 Purity ? 98 %
    2.4 Purity ? 99 %
3. Covid-19 Impact Bortezomib API Sales Market by Application
    3.1 Global Bortezomib API Historic Market Size by Application
    3.2 Global Bortezomib API Forecasted Market Size by Application
    3.3 Injection
    3.4 Others
4. Covid-19 Impact Market Competition by Manufacturers
    4.1 Global Bortezomib API Production Capacity Market Share by Manufacturers
    4.2 Global Bortezomib API Revenue Market Share by Manufacturers
    4.3 Global Bortezomib API Average Price by Manufacturers
5. Company Profiles and Key Figures in Bortezomib API Business
    5.1 Scion Pharm Taiwan
        5.1.1 Scion Pharm Taiwan Company Profile
        5.1.2 Scion Pharm Taiwan Bortezomib API Product Specification
        5.1.3 Scion Pharm Taiwan Bortezomib API Production Capacity, Revenue, Price and Gross Margin
    5.2 Vinkem Labs
        5.2.1 Vinkem Labs Company Profile
        5.2.2 Vinkem Labs Bortezomib API Product Specification
        5.2.3 Vinkem Labs Bortezomib API Production Capacity, Revenue, Price and Gross Margin
    5.3 Shilpa Medicare Limited
        5.3.1 Shilpa Medicare Limited Company Profile
        5.3.2 Shilpa Medicare Limited Bortezomib API Product Specification
        5.3.3 Shilpa Medicare Limited Bortezomib API Production Capacity, Revenue, Price and Gross Margin
    5.4 Farmhispania Group
        5.4.1 Farmhispania Group Company Profile
        5.4.2 Farmhispania Group Bortezomib API Product Specification
        5.4.3 Farmhispania Group Bortezomib API Production Capacity, Revenue, Price and Gross Margin
    5.5 Icrom
        5.5.1 Icrom Company Profile
        5.5.2 Icrom Bortezomib API Product Specification
        5.5.3 Icrom Bortezomib API Production Capacity, Revenue, Price and Gross Margin
    5.6 Tapi Teva
        5.6.1 Tapi Teva Company Profile
        5.6.2 Tapi Teva Bortezomib API Product Specification
        5.6.3 Tapi Teva Bortezomib API Production Capacity, Revenue, Price and Gross Margin
    5.7 Chem-Stone(Guangzhou)
        5.7.1 Chem-Stone(Guangzhou) Company Profile
        5.7.2 Chem-Stone(Guangzhou) Bortezomib API Product Specification
        5.7.3 Chem-Stone(Guangzhou) Bortezomib API Production Capacity, Revenue, Price and Gross Margin
    5.8 Gland Chemicals
        5.8.1 Gland Chemicals Company Profile
        5.8.2 Gland Chemicals Bortezomib API Product Specification
        5.8.3 Gland Chemicals Bortezomib API Production Capacity, Revenue, Price and Gross Margin
    5.9 Dr. Reddy's Laboratories
        5.9.1 Dr. Reddy's Laboratories Company Profile
        5.9.2 Dr. Reddy's Laboratories Bortezomib API Product Specification
        5.9.3 Dr. Reddy's Laboratories Bortezomib API Production Capacity, Revenue, Price and Gross Margin
    5.10 Qilu Pharmaceutial
        5.10.1 Qilu Pharmaceutial Company Profile
        5.10.2 Qilu Pharmaceutial Bortezomib API Product Specification
        5.10.3 Qilu Pharmaceutial Bortezomib API Production Capacity, Revenue, Price and Gross Margin
    5.11 Chengdu Aslee Biopharmaceuticals
        5.11.1 Chengdu Aslee Biopharmaceuticals Company Profile
        5.11.2 Chengdu Aslee Biopharmaceuticals Bortezomib API Product Specification
        5.11.3 Chengdu Aslee Biopharmaceuticals Bortezomib API Production Capacity, Revenue, Price and Gross Margin
    5.12 Coresyn
        5.12.1 Coresyn Company Profile
        5.12.2 Coresyn Bortezomib API Product Specification
        5.12.3 Coresyn Bortezomib API Production Capacity, Revenue, Price and Gross Margin
    5.13 Hubei Honch Pharmaceutical
        5.13.1 Hubei Honch Pharmaceutical Company Profile
        5.13.2 Hubei Honch Pharmaceutical Bortezomib API Product Specification
        5.13.3 Hubei Honch Pharmaceutical Bortezomib API Production Capacity, Revenue, Price and Gross Margin
6. North America
    6.1 North America Bortezomib API Market Size
    6.2 North America Bortezomib API Key Players in North America
    6.3 North America Bortezomib API Market Size by Type
    6.4 North America Bortezomib API Market Size by Application
7. East Asia
    7.1 East Asia Bortezomib API Market Size
    7.2 East Asia Bortezomib API Key Players in North America
    7.3 East Asia Bortezomib API Market Size by Type
    7.4 East Asia Bortezomib API Market Size by Application
8. Europe
    8.1 Europe Bortezomib API Market Size
    8.2 Europe Bortezomib API Key Players in North America
    8.3 Europe Bortezomib API Market Size by Type
    8.4 Europe Bortezomib API Market Size by Application
9. South Asia
    9.1 South Asia Bortezomib API Market Size
    9.2 South Asia Bortezomib API Key Players in North America
    9.3 South Asia Bortezomib API Market Size by Type
    9.4 South Asia Bortezomib API Market Size by Application
10. Southeast Asia
    10.1 Southeast Asia Bortezomib API Market Size
    10.2 Southeast Asia Bortezomib API Key Players in North America
    10.3 Southeast Asia Bortezomib API Market Size by Type
    10.4 Southeast Asia Bortezomib API Market Size by Application
11. Middle East
    11.1 Middle East Bortezomib API Market Size
    11.2 Middle East Bortezomib API Key Players in North America
    11.3 Middle East Bortezomib API Market Size by Type
    11.4 Middle East Bortezomib API Market Size by Application
12. Africa
    12.1 Africa Bortezomib API Market Size
    12.2 Africa Bortezomib API Key Players in North America
    12.3 Africa Bortezomib API Market Size by Type
    12.4 Africa Bortezomib API Market Size by Application
13. Oceania
    13.1 Oceania Bortezomib API Market Size
    13.2 Oceania Bortezomib API Key Players in North America
    13.3 Oceania Bortezomib API Market Size by Type
    13.4 Oceania Bortezomib API Market Size by Application
14. South America
    14.1 South America Bortezomib API Market Size
    14.2 South America Bortezomib API Key Players in North America
    14.3 South America Bortezomib API Market Size by Type
    14.4 South America Bortezomib API Market Size by Application
15. Rest of the World
    15.1 Rest of the World Bortezomib API Market Size
    15.2 Rest of the World Bortezomib API Key Players in North America
    15.3 Rest of the World Bortezomib API Market Size by Type
    15.4 Rest of the World Bortezomib API Market Size by Application
16 Bortezomib API Market Dynamics
    16.1 Covid-19 Impact Market Top Trends
    16.2 Covid-19 Impact Market Drivers
    16.3 Covid-19 Impact Market Challenges
    16.4 Porter?s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
    18.1 Research Methodology
        18.1.1 Methodology/Research Approach
        18.1.2 Data Source
    18.2 Disclaimer

Market Segmentation

By Type

  • Purity ≥ 98%
  • Purity ≥ 99%

By Application

  • Injection
  • Others

Regional Analysis

  • North America: U.S., Canada, Mexico
  • Europe: Germany, U.K., France, Italy, Russia, Spain, others
  • Asia-Pacific: China, India, Japan, Southeast Asia, others
  • South America: Brazil, Argentina, others
  • Middle East & Africa: Saudi Arabia, South Africa, others

Competitive Landscape

Top key players covered in the Bortezomib API market include:

  • Scion Pharm Taiwan
  • Vinkem Labs
  • Shilpa Medicare Limited
  • Farmhispania Group
  • Icrom
  • Tapi Teva
  • Chem-Stone (Guangzhou)
  • Gland Chemicals
  • Dr. Reddy's Laboratories
  • Qilu Pharmaceutical
  • Chengdu Aslee Biopharmaceuticals
  • Coresyn
  • Hubei Honch Pharmaceutical

Upto 24 to 48 hrs (Working Hours)

Upto 72 hrs max (Working Hours) - Weekends and Public Holidays

Single User License - Allows access to only one person to the report.

Multi User License - Allows sharing with max 5 persons within organization.

Corporate License – Can be shared across entire organization.

Online Payments with PayPal

Wire Transfer / Bank Transfer

Why Choose Us

24/7 Expert Support

At ChemReports, we understand that business decisions can’t wait. Our research specialists are available anytime to answer your queries and guide you through our reports, ensuring quick and reliable assistance.

Comprehensive Market Coverage

ChemReports provides 360° market analysis across materials, technologies, and global chemical sectors—helping you make confident business decisions.

Actionable Intelligence

We turn complex data into strategic insights to support fact-based decisions, market entry strategies, and competitive analysis.

Data Privacy & Security

Your personal and business information is completely secure with us. We value your trust and ensure strict confidentiality.

Customized Research

Need tailored insights? Our analysts provide custom reports built on authentic data and aligned with your specific business goals.

FAQs

Yes, we are providing all research support to get resolve all queries and concerns regarding the report. For all our clients.
Yes, we are providing complete customization in every report to fulfill your business needs.
Yes, we are providing regional and countries level analysis in the report, please mention the countries you are looking.
Yes, we are providing a discount for individuals and startups.
We offer access to more than one million market research reports. If the specific topic you need is not listed on our website, simply email us your requirements at sales@chemreports.com. Our research team will review your request and provide a customized report or the most relevant available study. We?re always happy to assist you with tailored solutions.